INSIGHTS ON CLINICAL TRIAL DESIGN

• In Search Of A Cure For Low Enrollment In Oncology Clinical Trials

  Delayed enrollment can cost oncology trials up to $250K per patient. Explore the barriers keeping patients out and practical ways to reach more of them faster.

• The Triple Effect Of Community-Based Clinical Trials

  Taking trials into local communities improves access, boosts enrollment, reduces dropouts, and yields more representative data, speeding timelines and strengthening study quality.

• Protocol Design Choices That Trigger IRB And Regulatory Requirements

  Learn how protocol choices like AI, adaptive designs, and decentralized methods impact IRB review, participant protections, consent, and key regulatory requirements in clinical research.

• Expectations For Plain Language Summaries Continue To Evolve

  Plain language summaries (PLS) are growing in importance as a requirement in global transparency. Focusing on protocol and results summaries, we cover expectations and best practices for global PLS implementation.

• Why RWD Strategy Can't Wait With Price, Value And Evidence Pressures Everywhere

  4/27/2026

  Overcome pricing pressures and reimbursement delays by integrating real-world evidence early in development to align clinical outcomes with payer demands and accelerate patient access.

• How Some Patient Organizations Are Driving Drug Development

  9/17/2026

  Discover how patient-led registries are becoming a practical source of real-world evidence, drug repurposing insight, and smarter trial design.

• Advancing Immunotherapy In Head And Neck Cancer: The IT-MATTERS Study

  4/17/2025

  This randomized controlled pivotal Phase 3 study evaluated efficacy and safety of neoadjuvant complex biologic administered for three consecutive weeks pre-surgery.

• Achieving A 2.67x Reduction In Study Build Time For An Innovative Neuromodulation Study

  12/20/2024

  This study explores the potential of Focused Ultrasound Neuromodulation in deepening meditative states, and the platform that helps enhance the overall experience for researchers and participants alike.

• The Impact Of High Inflation And The Great Resignation On Clinical Site Budgeting

  10/30/2024

  The twin pressures of inflation and attrition prolong negotiations between sponsors and clinical sites, stalling drug development. Sponsors need up-to-date, reliable benchmark data to negotiate fair market value budgets.